Concepedia

Author

Q. Shao

Air Force Medical University

Also Known As

Q Shao, Q. Shao, Qianqian Shao, Qingqing Shao, Qiu-Ju Shao, QiuJu Shao, Qiuju Shao, Shao Q

64

Publications

1.2K

Citations

16

H-Index

25

Concepts

All Affiliations

Air Force Medical UniversityTang Du HospitalNovartis (United States)Novartis (Switzerland)Tris Pharma (United States)
QS

About

Q. Shao is an author at Air Force Medical University specializing in medicine, pathology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

200

2

Health Sciences

2

2

118

3

Cell Biology

2

2

118

4

Diabetes

1

1

82

5

Hepatology

1

1

54

Q. Shao

×

13

Publications

877

Citations

13

H-Index

YearCitations

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24‐week randomized placebo‐controlled trial

Valentina Lukashevich, Anja Schweizer, Q. Shao,

Diabetes Obesity and Metabolism

2011

146

One‐year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

Wolfgang Kothny, Q. Shao, Per‐Henrik Groop,

Diabetes Obesity and Metabolism

2012

103

Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials

Anja Schweizer, S. Dejager, James E. Foley,

Diabetes Obesity and Metabolism

2010

102

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Wolfgang Kothny, James E. Foley, Plamen Kozlovski,

Diabetes Obesity and Metabolism

2012

99

Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naïve Patients with Type 2 Diabetes: Comparison with Metformin

Burkhard Göke, Kenneth S. Hershon, Douglas A. Kerr,

Hormone and Metabolic Research

2008

92

Sustained Efficacy and Reduced Hypoglycemia during One Year of Treatment with Vildagliptin Added to Insulin in Patients with Type 2 Diabetes Mellitus

Vivian Fonseca, Michelle A. Baron, Q. Shao,

Hormone and Metabolic Research

2008

82

miR-144 reverses chemoresistance of hepatocellular carcinoma cell lines by targeting Nrf2-dependent antioxidant pathway.

Suna Zhou, Wenguang Ye, Yanjun Zhang,

PubMed

2016

64

MicroRNA-152 inhibits tumor cell growth by directly targeting RTKN in hepatocellular carcinoma

Jiejing Zhou, Yanjun Zhang, Yuhong Qi,

Oncology Reports

2016

54

MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma.

Suna Zhou, Wenguang Ye, Juan Ren,

PubMed

2015

44

Prognostic significance of XIAP and NF-κB expression in esophageal carcinoma with postoperative radiotherapy

Suna Zhou, Wenguang Ye, Q. Shao,

World Journal of Surgical Oncology

2013

35

Page 1